Other Diseases

Biovista has initiated preliminary profiling and screening of drugs for specific auto-immune and infectious diseases (HIV). We will be reporting on these efforts shortly.

Drugs coming off Patent

We are systematically repositioning all drugs that are losing exclusivity and coming off patent in the next 5 years and beyond. The Orange Book lists at least 100 such drugs, and we are currently processing 28 of them. To date, we have repositioned five Pfizer drugs, six Novartis drugs, and ten Roche drugs and we are working down the list of opportunities.

To find out more about our Pipeline, please contact us.